Desoximetasone

去羟米松

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDesoximetasone
Drug Alias Namedesoximetasona脱羟氟美松Desoximetasonum去烃米松去氧米松 +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisSkin Diseases +[4] 
Global Approved IndicationsSkin Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1977/02/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTaro
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaro Pharmaceutical Industries LtdHikma PharmaceuticalsTaro Pharmaceuticals Usa Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisPsoriasisSkin Diseases +[4] 

Other Information

ATC CodeD07AC03D07XC02
Related LinksWikipediaDrugBankKEGG